A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia.

Source:http://linkedlifedata.com/resource/pubmed/id/16301206

Download in:

View as

General Info

PMID
16301206